Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2 - PubMed (original) (raw)
Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2
Zehava Vadasz et al. J Hepatol. 2005 Sep.
Abstract
Background/aims: Lysyl-oxidases catalyze the oxidation of lysine residues in collagen and elastin thereby promoting their polymerization. We have studied here the expression of four lysyl-oxidases in normal and diseased human liver.
Methods: The expression of the different lysyl-oxidases in paraffin embedded liver sections was studied using in-situ hybridization and immunohistochemistry. The enzymatic activity of lysyl-oxidase like protein-2 (Loxl2 or LOR-1) using a previously described lysyl-oxidase assay.
Results: We have found that the four lysyl-oxidases which we examined are not significantly expressed in the normal liver. By contrast, Wilson's disease and primary biliary cirrhosis (PBC) patients express lysyl-oxidase (Lox) and lysyl-oxidase like protein-2 (Loxl2 or LOR-1) in hepatocytes, and the expression is accompanied by collagen deposition around the hepatocytes. Lysyl-oxidases are also expressed in additional fibrotic liver diseases such as hepatitis B and C but in these diseases the expression is confined to the fibrotic lesions and collagen does not accumulate around hepatocytes. We have found that Loxl2 is able to oxidize lysine residues of collagen, and behaves in that respect similarly to Lox. The copper chelator D-penicillamine inhibits Loxl2 induced oxidation of collagen but the Lox inhibitor beta-aminopropionitrile did not inhibit the oxidation using a BAPN concentration at which Lox activity was completely inhibited. Loxl2 also catalyzed the oxidation of cell surface proteins on HepG2 hepatoblastoma cells and inhibited their proliferation.
Conclusions: Upregulation of Lox and Loxl2 in hepatocytes of Wilson's disease and PBC patients may contribute to liver damage by various mechanisms. The upregulation of Lox and Loxl2 in Wilson's disease could perhaps be utilized for diagnostic purposes since their expression is up-regulated in hepatocytes even before the onset of fibrosis.
Similar articles
- Reciprocal regulation of LOX and LOXL2 expression during cell adhesion and terminal differentiation in epidermal keratinocytes.
Fujimoto E, Tajima S. Fujimoto E, et al. J Dermatol Sci. 2009 Aug;55(2):91-8. doi: 10.1016/j.jdermsci.2009.03.010. Epub 2009 Apr 24. J Dermatol Sci. 2009. PMID: 19394199 - A molecular role for lysyl oxidase in breast cancer invasion.
Kirschmann DA, Seftor EA, Fong SF, Nieva DR, Sullivan CM, Edwards EM, Sommer P, Csiszar K, Hendrix MJ. Kirschmann DA, et al. Cancer Res. 2002 Aug 1;62(15):4478-83. Cancer Res. 2002. PMID: 12154058 - Lysyl oxidase and the lysyl oxidase-like protein modulate odontoblastic differentiation of human dental pulp cells.
Kim EC, Lee HJ, Kim Y. Kim EC, et al. J Endod. 2012 Jun;38(6):769-73. doi: 10.1016/j.joen.2012.03.014. Epub 2012 Apr 21. J Endod. 2012. PMID: 22595110 - Lysyl Oxidase Family Enzymes and Their Role in Tumor Progression.
Liburkin-Dan T, Toledano S, Neufeld G. Liburkin-Dan T, et al. Int J Mol Sci. 2022 Jun 2;23(11):6249. doi: 10.3390/ijms23116249. Int J Mol Sci. 2022. PMID: 35682926 Free PMC article. Review. - Structural and functional diversity of lysyl oxidase and the LOX-like proteins.
Molnar J, Fong KS, He QP, Hayashi K, Kim Y, Fong SF, Fogelgren B, Szauter KM, Mink M, Csiszar K. Molnar J, et al. Biochim Biophys Acta. 2003 Apr 11;1647(1-2):220-4. doi: 10.1016/s1570-9639(03)00053-0. Biochim Biophys Acta. 2003. PMID: 12686136 Review.
Cited by
- The 2016 John J. Abel Award Lecture: Targeting the Mechanical Microenvironment in Cancer.
Majeski HE, Yang J. Majeski HE, et al. Mol Pharmacol. 2016 Dec;90(6):744-754. doi: 10.1124/mol.116.106765. Epub 2016 Oct 14. Mol Pharmacol. 2016. PMID: 27742780 Free PMC article. Review. - The potential for targeting extracellular LOX proteins in human malignancy.
Mayorca-Guiliani A, Erler JT. Mayorca-Guiliani A, et al. Onco Targets Ther. 2013 Nov 25;6:1729-35. doi: 10.2147/OTT.S38110. Onco Targets Ther. 2013. PMID: 24348049 Free PMC article. Review. - Proteomic Profiling of Human Prostate Cancer-associated Fibroblasts (CAF) Reveals LOXL2-dependent Regulation of the Tumor Microenvironment.
Nguyen EV, Pereira BA, Lawrence MG, Ma X, Rebello RJ, Chan H, Niranjan B, Wu Y, Ellem S, Guan X, Wu J, Skhinas JN, Cox TR, Risbridger GP, Taylor RA, Lister NL, Daly RJ. Nguyen EV, et al. Mol Cell Proteomics. 2019 Jul;18(7):1410-1427. doi: 10.1074/mcp.RA119.001496. Epub 2019 May 6. Mol Cell Proteomics. 2019. PMID: 31061140 Free PMC article. - Implications of lysyl oxidase-like protein 3 expression in the periodontium of diabetic rats.
Huang L, Chen J, Zuo Y, Li J, Yue Y, Wang M, Hao L. Huang L, et al. J Appl Oral Sci. 2022 Sep 19;30:e20220176. doi: 10.1590/1678-7757-2022-0176. eCollection 2022. J Appl Oral Sci. 2022. PMID: 36134856 Free PMC article. - LOX is a novel mitotic spindle-associated protein essential for mitosis.
Boufraqech M, Wei D, Weyemi U, Zhang L, Quezado M, Kalab P, Kebebew E. Boufraqech M, et al. Oncotarget. 2016 May 17;7(20):29023-35. doi: 10.18632/oncotarget.8628. Oncotarget. 2016. PMID: 27296552 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical